EPS for Avianca Holdings S.A. (AVH) Expected At $0.30; STARPHARMA HOLDINGS (SPHRF) Sellers Decreased By 30.87% Their Shorts

February 15, 2018 - By Linda Rogers

Analysts expect Avianca Holdings S.A. (NYSE:AVH) to report $0.30 EPS on February, 27.AVH’s profit would be $35.93 million giving it 7.04 P/E if the $0.30 EPS is correct. After having $0.31 EPS previously, Avianca Holdings S.A.’s analysts see -3.23% EPS growth. The stock decreased 0.59% or $0.05 during the last trading session, reaching $8.45. About 533,451 shares traded or 426.68% up from the average. Avianca Holdings S.A. (NYSE:AVH) has risen 35.97% since February 15, 2017 and is uptrending. It has outperformed by 19.27% the S&P500.

STARPHARMA HOLDINGS (OTCMKTS:SPHRF) had a decrease of 30.87% in short interest. SPHRF’s SI was 145,100 shares in February as released by FINRA. Its down 30.87% from 209,900 shares previously. With 100 avg volume, 1451 days are for STARPHARMA HOLDINGS (OTCMKTS:SPHRF)’s short sellers to cover SPHRF’s short positions. It closed at $1.03 lastly. It is down 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications primarily in Australia and Canada. The company has market cap of $392.56 million. The firm focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections. It has a 60.59 P/E ratio. It also develops dendrimer-enhanced, or DEP versions of existing drugs, including DEP docetaxel that is in Phase I clinical trial for breast, prostate, lung, and ovarian tumor.

Among 6 analysts covering Avianca Holdings SA (NYSE:AVH), 2 have Buy rating, 1 Sell and 3 Hold. Therefore 33% are positive. Avianca Holdings SA had 10 analyst reports since August 21, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Monday, July 11 by Bank of America. Deutsche Bank upgraded the shares of AVH in report on Thursday, November 16 to “Buy” rating. As per Friday, April 21, the company rating was downgraded by Deutsche Bank. The firm earned “Neutral” rating on Thursday, May 25 by JP Morgan. The rating was initiated by Standpoint Research with “Buy” on Friday, August 21. Standpoint Research downgraded Avianca Holdings S.A. (NYSE:AVH) on Wednesday, December 7 to “Reduce” rating.

Avianca Holdings S.A., through its subsidiaries, provides air transportation services in North America, Central America, the Caribbean, Colombia, South America, and internationally. The company has market cap of $1.01 billion. It offers passenger and cargo air transportation services; and aircraft maintenance, crew training, and other airport services to other carriers, as well as travel-related services to its customers. It has a 18.53 P/E ratio. The firm is also involved in ground activities for third??party airlines in airport hubs, and aircraft leasing activities; and operates LifeMiles, a frequent flyer program.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: